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Abstract
Background: This descriptive study aimed to investigate adolescents’ motivations for participating in a randomised
controlled trial (RCT), to explore the understanding that the young people had regarding a number of aspects of
the trial design, to examine whether or not they found participation in the trial to be acceptable and what affected
this, and to identify whether and how the young people felt that their participation in the RCT impacted on their
experience of therapy and on therapeutic change.
Methods: Seventy-six adolescents who were taking part in a large-scale RCT to evaluate the clinical and cost
effectiveness of psychological therapies for depression were interviewed at two time-points after completing
therapy. The semi-structured interviews, which included a focus on the young people’s experience of the research
study, were analysed using framework analysis.
Results: The vast majority of adolescents found it acceptable to participate in the clinical trial, and many agreed
to participate for reasons of ‘conditional altruism’. However consent was often given without great understanding
of the key elements of the trial, including the difference between treatment arms and the randomisation process.
Although the adolescents were largely positive about their experiences from taking part, the study raises questions
about whether clinical outcomes may be influenced by participation in the research elements of the trial.
Conclusions: Although adolescents are under-represented in clinical trials, those who do participate are generally
positive about the experience; however, careful thought needs to be given to key elements of the trial design
and the potential impact of the research participation on clinical outcomes.
Trial registration: ISRCTN registry, ISRCTN83033550. Registered on 15 October 2009.
Keywords: Randomised controlled trials, Trial participation, Patient understanding, Patient perspective, Parents,
Adolescence, Depression, Qualitative research, Framework analysis
Background
In the most recent edition of their comprehensive re-
view of ‘What works for whom?’ in the field of child
and adolescent mental health, Fonagy et al. [1]
expressed the view that randomised controlled trials
(RCTs) are ‘generally considered scientifically superior
to cohort or observational studies in answering the
question of whether a treatment is effective’ (p. 4).
Although these authors acknowledge the limitations of
RCTs, this opinion is shared by most developers of guide-
lines on evidence-based practice such as those developed
by the American Psychiatric Association in the USA or
the National Institute for Health and Clinical Evidence
in the UK.
Yet despite the importance of participation by adoles-
cents, relatively little is known regarding how and why
young people decide to participate in clinical trials, es-
pecially in the field of mental health, or how they then
experience involvement in such studies [2]. A recent
study by Brown et al. [3] noted that adolescents are
under-represented in clinical trials generally and that
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‘little is known about adolescents’ knowledge and atti-
tudes surrounding clinical trials’ (p. 213). Brown et al.’s
own questionnaire survey of 82 high school students in
Michigan found that only 33 % of those surveyed had
ever heard of a clinical trial, and understanding about
trials was poor. However, attitudes toward taking part
were somewhat more positive.
The literature examining the experience of adults who
have participated in clinical trials is somewhat more ex-
tensive. In a systematic review article by O’Cathain et al.
[2], 54 studies were identified which had examined the
design, process and conduct of clinical trials using quali-
tative methodologies. Among these were studies that ex-
amined how and why participants decided to take part
in clinical trials, their understanding of trial design and
whether trial design was considered acceptable to those
who took part.
Most research examining the views of adults taking
part in clinical trials has focused on studies evaluating
medical treatments. However, Notley et al. [4], in a
well-designed study examining the views of 13 young
adults on their involvement in a trial of social recovery
cognitive-behavioural therapy, found that practicalities
relating to participation, such as the time and location
of research meetings and flexibility in relation to these
from the research staff, were important factors in the
patient’s experience of taking part. Participants also
expressed positive surprise at their levels of disclosure
in research assessment meetings, and stated that this
might have happened as a result of the researcher being
supportive, non-judgmental and empathetic. Taken to-
gether, these findings may suggest that the patients’ ex-
perience of participation in a research trial is acceptable if
they experience research staff in such positive ways and if
they feel that they are getting something positive from the
experience of taking part in the trial.
When it comes to adolescents, a certain amount of lit-
erature exists in the field of physical health—especially
oncology—regarding the recruitment and decision-making
process as to whether to participate in research or not,
from the perspective of both adolescents and their parents
(e.g. [5–8]). Very few studies, however, have focused on
the experience of adolescents after they have chosen to
participate in a trial, and research related to young people’s
involvement in clinical trials evaluating the effectiveness of
psychological therapies is completely lacking.
In conclusion, whilst a reasonable amount of know-
ledge is available about the experience of adults who
have taken part in clinical trials in the field of medicine,
and a few studies that have looked at the experience of
those taking part in trials evaluating psychological ther-
apies, no research is available that explored the experi-
ence of adolescents participating in clinical trials of
psychological therapies, and relatively little research is
available on young people's participation in clinical trials
generally. Where such research has taken place, it has
mostly focused on the decision to participate, with less
attention paid to the experience of actually taking part
in a trial. But exploring such experiences is important
for two key reasons. First, it is essential to know whether
the core elements of clinical trials (recruitment, random-
isation, and on-going data collection) are understood
and found acceptable or not to adolescents. Such infor-
mation is crucial to inform the design of future clinical
trials in a way that is ethical for those being asked to
participate. Second, given the debates about the transfer-
ability of trial findings to the routine clinical practice [9],
it is important to understand, from the perspective of
the young people themselves, whether participating in
the trial impacted on the treatment they received. Was
the therapeutic impact of the intervention different be-
cause it was taking place in the context of a clinical
trial?
The aims of this study, therefore, were (1) to explore
adolescents’ understanding and motivations for partici-
pating in an RCT investigating the therapeutic efficacy
of three treatments for adolescent depression, (2) to ex-
plore whether or not the young people found participa-
tion in the trial to be acceptable and what affected this,
and (3) to explore whether and how the young people
felt that their participation in the RCT impacted on their
experience of therapy and upon therapeutic change.
Methods
Setting for the study
All the adolescents interviewed for this study were tak-
ing part in a large, multi-centre, randomised controlled
trial, the Improving Mood through Psychoanalytic and
Cognitive-Behavioural Therapy (IMPACT) Study (for
full details of the study, see [10]). IMPACT is a prag-
matic superiority trial comparing the relative clinical
effectiveness of three psychological treatments for ado-
lescent depression, with established evidence of efficacy
for evoking clinical remission in the short term (i.e. 3–
6 months). The three treatment approaches tested in
this study were a manualised form of specialist clinical
care termed brief psychosocial intervention (BPI),
short-term psychoanalytic psychotherapy (STPP) and
cognitive behavioural therapy (CBT).
Participants and recruitment
Potential participants in the IMPACT trial were identi-
fied by clinical staff from routine referrals to the partici-
pating Child and Adolescent Mental Health Service
(CAMHS) clinics. The assessing clinicians informed the
young person and the parents/carers about the trial and
invited them to consider taking part. They were told that
the study team would be in touch if they expressed an
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interest to participate, and that recruitment would de-
pend on research assessments of whether the patient
met the inclusion and the exclusion criteria.
The participants and their parents or legal guardians
were then sent information sheets about the trial and
were asked if they were willing to be contacted by a re-
searcher, who then met participants and invited them to
sign a consent form. In agreeing to participate in this
pragmatic clinical trial, the young people were agreeing
to be randomised to one of the three treatment arms. As
the trial was examining levels of relapse in the medium
term, participants were also agreeing to attend six re-
search assessment meetings across an 86-week period, in
each of which they and their parents or carers were
asked to complete a substantial number of structured
assessments. These assessments were a mixture of struc-
tured interviews and self-report questionnaires on vari-
ous aspects of their psychological well-being, and usually
took approximately 1.5 hours to complete (for full
details, see [10]). The information sheet explained that
young people would be offered a £10 voucher for at-
tending each assessment meeting (see [10]). Following
randomisation, all patients in the trial were treated by
appropriately trained and supervised CAMHS staff
working in the participating clinics.
A total of 465 young people were recruited to the
IMPACT study, with a mean age of 15.6 years (SD 1.4).
A total of 348 (75 %) were females, and 117 male
(25 %). Of these participants, 85 % (382/450) described
their ethnicity as White British. At the point at which
the young people had been recruited to the study, all
met the diagnostic criteria for moderate to severe de-
pression, based on the Kiddie-SADS [11]. The IMPACT
study took place across different parts of the UK; the
recruitment numbers were 127 for North London, 185
for East Anglia and 153 for the North-West (Manchester
and the Wirral). Findings regarding the comparative
clinical and cost effectiveness of the interventions are
expected in 2016.
Alongside the IMPACT study, a sub-study known
as IMPACT-ME [12] aimed to explore the experi-
ence of the participants taking part in the London
arm of the IMPACT trial (for other findings from
this study, see [13–15]). Recruitment for this sub-
study began slightly later than the main clinical trial,
in September 2011, with all young people recruited
in London being asked for additional consent to take
part in two semi-structured interviews taking place
36 weeks and 86 weeks after they had joined the
IMPACT trial. The participants for the sub-study reported
in this paper, therefore, were 76 adolescents who were re-
cruited to the London arm of the IMPACT study between
September 2011 and December 2012 and who completed
at least one of the two post-therapy semi-structured
interviews. Closely matching the total sample in the
IMPACT trial, the average age of these 76 young people was
15.35 years, and 76 % were female. Based on a review of all
key characteristics, this sub-sample was broadly representa-
tive of the participants in the London arm of the trial itself.
Data collection
For the study reported here, a qualitative approach was
taken, as the aim was to allow the young people to de-
scribe in depth their experience of participating in the
trial, as well as their views of the psychological therapy
and their understanding of any changes in their depres-
sion that took place during and after therapy. We chose
qualitative research, because it aims to describe and
understand social or human phenomena. The research
process is reflexive and interactive and allows the partic-
ipants to express their experiences in their own words.
Verbal or visual data is interpreted based on distinct
methodological traditions to get a complex holistic pic-
ture [16]. In the current study, young people were inter-
viewed using a semi-structured protocol, the Experience
of Therapy Interview (ETI) (Midgley N, Ansaldo F, Par-
kinson S, Holmes J, Stapley E, Target M: Expectations of
therapy interview (young person and parent versions),
unpublished). The interview schedule covered three key
areas: the difficulties that brought the young person into
therapy, the participant’s experience of therapy, and how
it had been to participate in the IMPACT study.
Interviews were conducted on two occasions: at the
end of therapy (36 weeks) and again at 1-year follow-up
(86 weeks). These interviews were carried out at a differ-
ent time from the research assessment meetings for the
IMPACT trial itself and by a different team of re-
searchers (this was done primarily so that the research
assistants working on the IMPACT trial would not be
un-blinded to the treatment allocation, given that the
qualitative interviews included an in-depth exploration
of the young person’s experience of therapy; it also
aimed to make it easier for the young people to speak
openly about their experience of involvement in the trial,
including both positive and negative aspects). In line
with guidance on qualitative interviewing, researchers
were encouraged to follow the young person’s lead, but
follow up with further questions in order to gain as deep
an understanding as possible of their experience. All inter-
views for this sub-study were carried out by post-graduate
psychologists, who were given a half-day training session
in semi-structured interviewing using the ETI, and were
offered feedback on interviewing technique following their
initial interviews with young people.
Interviews were audio-recorded with interviewee con-
sent. The interviews at 36 weeks took place between
October 2011 and January 2014, and the interviews at
86 weeks between August 2012 and January 2015;
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70.5 % of the young people had interviews at both time
points. All interviews took place in the young person's
home or at their local CAMHS, depending on the
young person’s preference.
Data analysis
All interviews were transcribed and then analysed using
framework analysis (FA) [17], a method of qualitative
data analysis that was originally developed in the context
of social policy research in the UK but has recently be-
come increasingly popular in the fields of nursing and
psychology. Sitting within the family of broadly ‘the-
matic’ approaches, FA provides a flexible but structured
approach to data management and data analysis, which
is especially suitable for studies which have quite focused
research questions, a relatively large amount of qualita-
tive data that needs to be managed, and a priori issues
to investigate [18]. It also lends itself to studies where
qualitative data analysis is carried out by a team work-
ing together, rather than an individual researcher. The
approach has also been integrated with the NVivo10
qualitative software package [19], which was used in
this study.
We followed the five stages of framework analysis, as
outlined by Ritchie and Spencer [17]. Two of the authors
(DI and KW) developed a coding framework focusing on
the main research questions, under the supervision of
NM and MT. They coded the first 20 interviews to-
gether with the aim to develop a comprehensive, consist-
ent and clear coding framework. The first author then
coded a number of additional interviews using this
framework, to ensure that it was sufficient, comprehen-
sive and reliable. Further revisions were made to the
coding framework based on this process, and then, DI
and KW continued to code the remaining interviews
using the coding framework. In addition to the inductive
coding based on the framework, each case was coded at
a global level in terms of main motivation for participa-
tion, general acceptability of participation, and the over-
all understanding/lack of understanding of participating
in the RCT. Based on these ‘global’ ratings, frequencies
will be reported in the results section. (A more detailed
account of the use of framework analysis in this study
can be found in [20]).
Results
Findings are presented in three sections, following the
three research aims of the study. Each section is re-
ported in a narrative form, but numbers are given to in-
dicate how common each theme was. However, not all
participants made reference to experiences that related
to every category within the framework, and in some
cases, data from one interview could be coded to several
categories (for example, when a young person spoke
about several reasons for choosing to participate in the
study); therefore, the total number of young people re-
ported for each category does not always add up to 76.
In our findings, the terms ‘young people’ and ‘adoles-
cents’ are used interchangeably.
Young people’s understanding and motivations for
participating in the RCT
Although the semi-structured interview did not set out
to systematically assess the level of understanding of
the trial design, the way young people spoke about the
IMPACT study revealed their various understandings of
different elements of the research, including the study
objectives, key features of the design such as random-
isation, and the relationship between treatment and re-
search. Overall, 34/76 participants demonstrated an
understanding of the study, compared to 33/76 who
seemed to have a general lack of understanding. One
young person expressed a lack of understanding in the
following way:
I probably didn’t understand it as well as I should
have. I don’t even know the one I’m doing now, it’s
really bad. Because I was reading them and they all
kind of sounded the same to me, apart from one with
antidepressants or something. I didn’t really know
the differences, I was just thinking I’m getting therapy,
that’s that. (female, 16)
Whilst some participants demonstrated their under-
standing that the study was aiming to help young
people with depression, others showed a more detailed
understanding that the study aimed to compare thera-
peutic efficacy of three different types of treatment:
As far as I know it’s to do with working out what
type of therapy works best for teenagers or people,
I think it’s from 11 to 16 or something. Cos there
was Cognitive Be- there was cognitive therapy,
psychotherapy…um, one that was a bit more like
counselling…and I think there was one other one.
And then like we all got picked one at random and
then…they checked – so they monitored us to see if
we were getting better and then, from that they’d do
something sciency and then work out which one’s best.
(female, 14)
Despite the fact that approximately half of the young
people did not seem to fully understand what the trial
was about, these participants were nevertheless able to
offer a number of different reasons why they had
agreed to participate in the study. Of all those men-
tioned, helping others or contributing to understanding
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of depression was the most common, with 36/76 partic-
ipants raising this:
Well, I don’t know how much I’m helping but just
knowing, just knowing that even if I contribute by one
percent in helping another individual then I think
that’s just, it’s better than zero percent. (female, 16)
Thirteen of 76 young people spoke about their participa-
tion in the study in relation to getting treatment or help.
Although it was made clear that they would receive an
intervention whether or not they chose to participate in
the trial, these adolescents described how they believed
that taking part in the study would lead them to getting
help or treatment. More specifically, three young people
spoke of motivation to take part in the study due to a belief
that they would getter better help or treatment, as every-
thing would have to be ‘done by the books’. For one partici-
pant, the prestige of the study seemed to influence how
the participant perceived the treatment to be received:
It just sounded like it sounded like bigger, like more
successful, and…that it might actually be able to
help me. (female, 16)
Furthermore, five young people stated that they partic-
ipated in the study because they believed it would offer
them quicker access to treatment or help:
He offered me IMPACT or he was like ‘well you can
have normal therapy but you would have - but then
you would be put onto a waiting list’…So I was like,
yeah I’ll do IMPACT. (female, 17)
Eleven young people spoke about taking part in the
study because the research itself ‘sounded really interest-
ing’ (female, 15). Whereas one young person vehemently
stated that she did not think young people should be
paid for taking part, five others spoke of the money they
were paid for taking part as an important motivator.
I like the idea they pay you for it. I’m not gonna
lie (laughs). It’s really – it’s a very good incentive.
(female, 17)
Six participants spoke about how they liked the oppor-
tunity to be part of the research because it made them
feel less isolated. One young person spoke specifically
about the other people in the study and gave the impres-
sion that knowing that other young people were in the
same position as her was in some way reassuring:
It’s weird to think that so many other people over
the country are, like you know — people are coming
to their house as well, and they’re getting interviewed
and like spoken to. (female, 16)
The acceptability to young people of taking part
in the trial
Based on their interviews, 71/76 (93 %) of the partici-
pants found participation to be generally acceptable,
with only four finding participation to be generally un-
acceptable. One participant was fairly typical of this
positive view, when she said:
I think it’s been like quite a good experience… it feels
interesting I suppose to- to know that like you’re kind
of part of the study (female, 16)
More specifically, 21 young people talked about how
taking part in the study—in particular the regular re-
search assessment meetings—had helped them to see
the progress that they had made:
Yeah, it was a really good way. And although I
thought like, ‘Oh, you know like, why do they have to
come. Like I’m better now’. But when they got here,
and I actually started like talking to them and like
doing the things I thought of…it felt good. It’s like you
really can see the progress you’ve made. (female, 16)
Despite the overall sense that participating in the trial
had been acceptable, 40 participants spoke about spe-
cific aspects that they had found less acceptable. The
questionnaires in particular seem to have been experi-
enced as too time consuming. Young people stated that
the questions were often repetitive, felt irrelevant, com-
pleting the questionnaires was tedious, and that it was
difficult to focus on completing the questionnaires be-
cause of the length. Furthermore, some felt that the
questionnaires were unreliable, as the questions often
asked about how one had been feeling within a specific
time-period, and they did not feel it was possible to an-
swer such questions accurately or meaningfully. Some
participants also reported finding the interviews and
the questions asked somewhat intrusive or invasive, for
example questions about suicide. This participant was
fairly typical when he responded to a question about how
he felt the research should have been done differently:
Make [the research assessment meetings] not as long.
They’re quite long and there’s lots of questionnaires
and sometimes it’s difficult to answer everything
right cos you’re just kind of ticking off stuff…
Because sometimes you just – it gets to the point
where you’re just like ‘ok, getting a bit tired of this
now’ and then you don’t feel like what you’re saying
is particularly useful because it’s not not true but not
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–you’re just saying things as quickly as possible cos
you wanna stop. (male, 16)
On the other hand, 23 participants found completing
the questionnaires to be manageable, particularly as they
progressed through the study. (The number of measures
used in the study was reduced at later assessment points,
in the light of negative feedback from participants about
the baseline assessments). In addition, a few young
people reported that completing the questionnaires had
been helpful, enabling one to see a wider range of per-
spectives or views, helping one to see change and en-
couraging one to think and examine their difficulties
and develop a better understanding.
There’s like loads of questions but like it really
makes you think about stuff and it really like
examines everything and even though I don’t like
examining… it’s kind of like, I dunno, it felt like
more helpful - like I thought about things that could
be related, that wasn’t like my phobias and stuff
and I was just like… it definitely - it definitely helped
me understand myself a bit more. (female, 16)
Just under half (35/76) of the young people spoke
about the process of randomisation, and of these, 15
showed an understanding of the randomisation process,
most commonly explaining that randomisation made
things fair:
I think it’s a good method… It’s not biased or anything
so, yeah, so that’s better, randomly allocating them.
(female, 15)
In comparison, 20 participants seemed to have a lack
of understanding or, in a few cases, explicit misunder-
standing about randomisation. Some had a difficult
time remembering the randomisation process, and one
questioned whether it had actually taken place. Most
commonly, the belief was expressed that within ran-
domisation, the professionals would have chosen the
treatment that was best for their individual needs. This
was stated explicitly by seven young people:
I just thought well they would know what, which
treatment would be best for me so I didn’t really
think about it that much. (female, 16)
For 14 participants, being randomised to a treatment
was a source of concern for them regarding their partici-
pation in the trial. Anxieties about not knowing which
therapy one will get, a feeling of a lack of information
about each therapy leading to anxiety about being allo-
cated a ‘bad’ one, or one that would not suit their needs
or work, or believing that some were not even designed
to treat depression were present in the narratives of
these young people. They expressed that it would have
been better if choice was given rather than random allo-
cation; choice based on knowledge of the young person
and their needs. One young person described feeling
‘annoyed’ at the possibility that there could have been a
therapy better suited to them:
I think maybe the random allocated way about it
isn’t really the right way to go cos there’s obviously
some people with worse issues than others, so if
there’s different things that you can choose from,
why would you randomly put them in, would you
not want to kinda look at their background or ‘this
would be better for that person, this would be better
for that person’? (female, 15)
Furthermore, 11 young people were unhappy about
the outcome of the randomisation process, stating that
they would have preferred a different treatment arm as
they felt it would have been more helpful. Others
expressed a wish to try all three to see which would
work best for them. However, very few young people
seemed to have a clear understanding of what the three
different treatment options involved. For one young
person, the idea that the three possible treatments were
different seemed to mean that they were not all treat-
ments for depression; however, when this was explained
to the participant by a research assistant, the partici-
pant seemed to gain greater understanding about the
relative aims of each treatment:
Oh no it was, it was before they actually told me
about it ‘cause I thought they were, like I knew they
were the all the same thing, but I didn’t realise they
were helping for the same thing. ‘Cause when she
said it was three different treatments, I thought they
were completely different, but when she explained it,
I realised they were all actually related, and to do
with the same thing. (female, 16)
Thirty-eight of the participants spoke about finding it
difficult to remember the differences between the treat-
ment options, and perhaps most significantly, when they
could remember that there were three options, they re-
ported that they all sounded the same or that it was dif-
ficult to know what the difference was between them.
When asked how they felt about the randomisation
process, one young person stated:
I probably didn’t understand it as well as I should
have. I don’t even know the one I’m doing now, it’s
really bad. Because I was reading them and they all
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kind of sounded the same to me, apart from one with
antidepressants or something. I didn’t really know the
differences, I was just thinking I’m getting therapy,
that’s that. (female, 16)
Despite not fully understanding how the treatment op-
tions differed, 22 young people seemed to find the ran-
domisation process fairly acceptable, particularly once
they had been reassured that all three treatment arms
were expected to be effective. In addition, they expressed
that they were happy to be getting help, regardless of the
treatment arm to which they were allocated, or that their
lack of experience and knowledge about therapy meant
that it would be better to ‘leave it to the experts’. The
idea that randomisation was a ‘fair’ and ‘not biased’ way
to decide which therapy each young person received was
also expressed. In contrast to those unhappy about the
outcome, 22 others seemed to be happy about the treat-
ment allocated to them. These young people seemed to
feel that they had been given ‘the correct’ treatment or
the one they were hoping to get, or that any of the treat-
ments would have been helpful.
Of all the elements of the research, the topic that partic-
ipants spoke most often about was the meeting with the
research assistants. Fifty-five of 76 of the young people
reported positive experiences with the research assistants,
which seemed to contribute to acceptability of participa-
tion. Research assistants were described as friendly, nice,
easy to talk to, not judgemental, polite and interested. Par-
ticipants reflected that flexibility from the research assis-
tants in terms of location and timing of meetings and the
questions asked during the meetings made them feel more
comfortable and enabled them to talk. They also described
that it felt more like they were talking to a peer, that is,
more normal and less formal, perhaps because the re-
search assistants were closer in age than their therapists:
They’d come to me so I was at my house, so I felt
more comfortable. Rather than going to someone that
I don’t really know, and going to a place that I’ve
never been to before, you just felt more comfortable…
and if I wanted to change to different question we
could, and then we could come back to it. (female, 15)
However, 14 participants reported less positive experi-
ences of the meetings with the research assistants. It was
described as ‘weird’, ‘strange’, and ‘scary’ to have the re-
search assistants come to the young person’s house and
for the participant to tell this new person about their dif-
ficulties. For one young person it also felt ‘heavy’ to be
asked questions about their difficulties, and another de-
scribed disliking the approach that a research assistant
took in persisting with a line of questioning, when the
participant had given an answer.
The nature of the study was such that different re-
search assistants met with the adolescents over time.
Twenty-one of the participants reflected that they did
not mind changes in the research assistants to whom
they spoke. For some, not seeing previous research assis-
tants again meant that they could talk more openly; for
others, the feeling was expressed that changes in the re-
search assistants did not matter, as they were not there
to develop close relationships but to ask questions. How-
ever, 26 young people seemed to value the consistency
in the research assistants they met with and found in-
consistency to be more unacceptable. Having to start all
over again with a new person seemed to make it more
difficult and less comfortable for the young people to
talk about their experiences:
To see so many different faces and to explain your
story over and over and over again it is hard, it is
difficult… I don’t know how many people I’ve had -
I’ve had well over 20 people come to this house
and see me and I’ve had to explain my story every
single time. (female, 14)
For 14 participants, the fact that the therapy and the
research meetings were tape recorded was described as
‘weird’ or ‘awkward’. Young people seemed to feel con-
scious of the recorder and the fact that there would be a
record of what they were saying. This seems to have
contributed to a feeling that it was ‘scary’ to be tape re-
corded. However, 29 participants stated that they got
used to the tape recorder over time, and that it did not
seem to be something that bothered them or that they
thought too much about:
It wasn’t too bad… I mean I didn’t really pay
attention to the recorder that much… I mean
I would occasionally look at it but I wouldn’t really…
be wary of what I’m saying knowing that I’m being
recorded. (male, 17)
How participating in the trial impacted on the experience
of therapy and therapeutic change
During their interviews, 40/76 participants spoke about
the relationship between the therapy they were receiving
and the study itself. This was predominantly in an indir-
ect manner, whilst describing how they thought of their
therapy and their participation in research meetings. Of
these, 15 young people seemed to perceive research
and therapy to be one and the same or to have a sig-
nificant amount of confusion or lack of clarity over the
differences between research and therapy. Quite often
this was demonstrated in the way they used the term
‘IMPACT’ to refer both to the therapy they received
and the study itself. In some cases, the interview
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process itself made them aware of their confusion, as
in the following exchange:
I: How did you feel about those
[research assessment] meetings…
P: They were alright… I thought they were just part
of the therapy…
I: Right okay…
P: Well not part of the - cos they did ask me about
my depression and stuff
I: Yeah…
P: Wait, are you the same people? (male, 17)
The other 25 participants who spoke about the rela-
tionship between the treatment and research did appear
to have an idea that they were distinct from one another,
but how they saw this distinction was often quite varied.
As one put it:
Cos obviously it’s not exactly the same as being in
a room with your therapist, I mean it’s not exactly
the same. I mean with these researchers you can say
how your moods and stuff are, but with your therapist
you can say like what has actually gone on altogether.
(male, 15)
Interestingly, some of these young people could see
similarities between the research and therapy even
though, fundamentally, they knew that they were distinct
things:
It almost feels like they’re the same thing but…
they’re not […] Well the research is much more
direct. I’m asked questions as opposed to I say what
I want to say and sometimes it’s a bit more intense
than just sitting there talking to someone. But it’s –
it feels just fairly similar. (male, 16)
Of the 32 participants who spoke about the relation-
ship between therapy and research meetings, 24 stated
that they preferred the research assessment meetings.
Amongst the reasons for this were the flexibility in hav-
ing research meetings at home; questionnaires making
one think about and examine things to a greater extent
than therapy; a feeling that research assistants were eas-
ier to relate to, e.g. being closer in age, ‘friendlier’ and
‘more understanding’ than the professionals in CAMHS;
and the meetings with researchers were ‘less formal’:
I think I enjoyed [the meetings with the research
assistant] more than the weekly therapist’s. Because
she’s really nice and she’s more near my age and I
think that’s why I feel more comfortable with her,
because we kind of talk about the same kind of stuff
and almost have the same kind of interests and
I think it’s easier when you’re talking to someone
who’s close to your age, than someone who’s a lot
older because they’ll understand more. So I felt a bit
more comfortable with [the researcher]. (female, 16)
On the other hand, eight participants stated that they
preferred therapy over research. Amongst the reasons
for this was the feeling that the therapist actually lis-
tened as opposed to the researchers who just asked
questions, the feeling that therapy was more useful, and
that participants could speak about what they wanted to
speak about. For some young people, the fact that ther-
apy seemed to be more formal—which others had found
a negative point—helped them to trust the therapist
more than the research assistants:
With therapy I think it was more on a formal level
but then it was satisfying cos I could talk to her
about anything that I really wanted to, but like I
trusted her more the person more than like with the
research. (female, 15)
Thirty-one participants spoke about a range of ways in
which participating in the study and having regular re-
search assessment meetings impacted on the outcome of
therapy and in recovery from depression. Four spoke
about how participating in the study gave them the sense
of being monitored or followed up on and that this was
helpful, regardless of whether they found the therapy
helpful or not.
I’ve really, really liked it, I mean just… having
somebody have a little check up with you and
knowing that… for instance although therapy didn’t
work for me, I’m pretty sure that if I started feeling
really bad again like IMPACT - I felt as if I could
trust them that they would try and like sort something
out for me. It’s just they’ve kinda always been in the
background. (female, 17)
Three young people spoke about how being part of
the study alongside therapy gave them the sense that
they were not alone in their depression and that others
must be going through similar difficulties.
Like I think once you guys sent me this sheet thing
and it had all these like facts on it, and it was like
how many people are in the study. And I couldn’t
believe it. Cos obviously like me, like I know – well,
I don’t know for sure – but I’m sure most of the
people that I know, that I’m around, aren’t going
through, or haven’t been through anything. So I just
think I’m a bit of the odd one out. But then knowing
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that so many other people in the country that are
going through it, it makes it makes you feel a little
bit less…weird. (female, 16)
Three young people also spoke about how participat-
ing in the study helped them to attend all therapy ses-
sions either as a result of the knowledge that therapy
was time-limited or because it helped them to become
aware of the progress that they were making:
I think because of the study there’s more structure to it,
like I knew that it was only gonna be like 20 [sessions],
and I knew when I’d be meet - there was just more, it
was just more structured so I knew like how long I
had… (female, 16)
There was a range of other ways in which adolescents
felt that participating in the study had positively im-
pacted on the outcome of their depression. Fifteen
young people reported finding the opportunity to talk
about their difficult experiences in the research assess-
ment meetings as a positive or helpful aspect of the
study:
I mean these little sessions were helpful in a way
that I could…talk about most things, whereas I don’t
really talk about any of this stuff with anyone else …
they were helpful in that sort of way. (male, 17)
On the other hand, 24 young people felt that participa-
tion in the study did not have an effect on the outcome
of their therapy. Eleven of these stated that they simply
felt that participation did not have an effect, partly be-
cause they would have gone to therapy anyway:
I don’t think it made any difference, because I was
going to therapy anyway, so, I didn’t realise I was
part of a study. Well it’s not that I didn’t realise it’s
that I just, forgot about it. (female, 13)
A further 12 young people stated that their participa-
tion in the study did not come up in therapy, and this
seemed to imply that because it did not come up in ther-
apy, it did not have an impact on their outcomes.
Discussion
This study aimed to investigate adolescents’ experi-
ences of participating in an RCT. More specifically, the
aim was to explore three areas in relation to the par-
ticipant experience: motivation to participate, whether
or not participation was found to be acceptable and
what affected this, and whether and how participation
had impacted on their experience of therapy and thera-
peutic change.
Regarding reasons for participating, Ferguson [21] re-
ported that most adult patients do not feel they have a
‘moral duty’ to agree to take part in clinical trials,
whereas McCann, Campbell and Entwistle [22] suggest
that decisions to do so are often altruistic. McCann et
al. highlighted the willingness to contribute towards
furthering scientific knowledge as a major reason, but
noted that this is best understood as a form of ‘condi-
tional altruism’, as patients also hope that they will
benefit themselves. This is consistent with the findings
of our study, where a significant proportion (43 %) sug-
gested that helping others and contributing to wider
understanding was their main motivation for participat-
ing in the trial. Other reasons (such as the hope of get-
ting quicker access to treatment, or simply because the
research sounded interesting) might indicate a hope for
more personal gain, but as with the findings of McCann
et al. [22] regarding adults, these different motivations
are not contradictory, and it may well be that a form of
‘conditional altruism’ was also characteristic of most
young people.
To what degree their consent to participate can be
considered fully informed, however, is questionable, as
considerable levels of confusion existed among our par-
ticipants about what a randomised clinical trial entails.
The proportion of those who demonstrated understand-
ing (45 %) was hardly different from those who appeared
not to understand (43 %), with specific problems re-
ported by a fair number of adolescents regarding their
understanding of the process of randomisation or the
difference between what was being offered in the three
treatment arms. These findings mirror the results of
studies on adult samples with similar rates of the ‘thera-
peutic misconception’ [23]. In a qualitative interview
study on middle-aged and older men with somatic pros-
tatic diseases, most participants recalled major aspects
of trial design, including the involvement of chance, but
most also held other co-existing views about their treat-
ment allocation like fate and individualised allocation
[24]. A similar struggle to recall the details of the study
was reported for a sample of patients on anti-psychotic
medication [25]. In this study the confusion about trial
processes and aims might have been due to difficulties
recalling details of the informed consent that they were
given weeks or months ago. Another possible explan-
ation might be that some young people did not fully
understand the study details in the first place, possibly
as a result of their depression, which is often accompan-
ied by difficulties with concentration [13].
Yet despite their limited understanding of the trial,
having taken part in the IMPACT study the vast propor-
tion of adolescents (93 %) found that it had been gener-
ally acceptable. In some cases this was because they had
positively valued what taking part in the research had
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provided (e.g. helping them to reflect on progress or
making them feel less isolated), but by far the greatest
reason was because they had valued the relationships
that they had formed with the research assistants who
had undertaken the assessment meetings and were ‘the
face’ of the study. The fact that these research assistants
were friendly, flexible and engaging was key to the young
people finding the study as a whole acceptable. Never-
theless, there were elements of the research with which
they were not entirely happy. Whilst some elements
were merely ‘awkward’ (such as the recording of therapy
sessions), the greatest dissatisfaction was with the re-
search questionnaires, which many young people felt to
be overly time consuming, repetitive and in certain re-
spects not meaningful. In some cases, this appears to
have had a significant impact on the validity of the data
produced, as some young people reported lacking the
motivation to meaningfully respond to the questions.
These findings are consistent with studies examining
the acceptability of trial design for adults in psycho-
logical therapy studies (e.g. [25–29]). For example, the
young women with post-partum depression treatment in
a study by Le et al. [28] spoke about finding question-
naires a helpful way to reflect on their own experiences.
Furthermore, the young women formed relationships
with the research team, which helped them to deal with
feelings of isolation. Likewise, the young adults in a trial
on social recovery CBT [4] generally reported quite high
levels of acceptance regarding trial participation, although
some aspects of the trial were criticized; for instance,
some questions on the questionnaires were experienced
as intrusive. Similar to the current study, the flexibility
of the research assistants was an important aspect of
acceptability.
The question of to what extent being part of the re-
search impacted on the participants’ depression itself is
a complex one, especially in a trial where the interven-
tion is a ‘talking therapy’, which in some way has similar-
ity to sitting down and speaking to a researcher. Our
study suggests that a considerable minority of adoles-
cents were confused about the difference between the
research and the therapy or saw them as two aspects of
the same thing. Interestingly, a considerable proportion
of young people directly compared their experience of
therapy with their meetings with the research assis-
tants, sometimes preferring the latter because they were
‘friendlier’, ‘more flexible’ and the researchers were more
like a peer than an adult. Clearly taking part in the re-
search study did impact on their well-being—mostly in
positive ways—such as reducing the sense of isolation
or giving the young people an opportunity to reflect on
the progress they had made. Although this is encour-
aging because it suggests that participating in an RCT
of this sort was generally a positive experience for these
young people, it does raise questions about the external
validity of the findings and whether participating in the
trial itself may have had a therapeutic impact.
Implications of the study for clinical trials evaluating the
effectiveness of psychological therapies with adolescents
Although caution is required in generalizing these find-
ings to other research settings, our study suggests the
following:
 As with adults, a range of reasons explain why the
young people have agreed to take part, but in most
cases, a form of ‘conditional altruism’ exists; that is,
they feel that taking part will help other people, but
they also hope that it may have a range of benefits
for themselves such as accessing treatment faster
or receiving a more high-quality intervention.
 Despite the under-representation of adolescents
in clinical trials generally, when adolescents do take
part in a clinical trial evaluating the effectiveness
of psychological therapies, most young people
generally find the experience acceptable.
 Factors that contribute to trial participation being
acceptable include the opportunity to reflect on
the changes they have made by routinely reviewing
their progress and the fact that research assistants
were friendly, flexible and worked hard to engage
with the young people. Clearly, recruiting highly
motivated research assistants and giving them
appropriate training and support to undertake this
task is essential if a trial of this sort is to be successful.
 Conversely, asking young people to fill in
questionnaires that are repetitive or time consuming
or that ask questions that do not seem relevant is
likely to have a negative impact on their willingness
to participate in clinical trials. Despite some
concerns among psychotherapists, the recording
of therapy sessions did not appear to be a major
obstacle for the young people in the study.
 Despite the general acceptability, greater effort
needs to be made to ensure that consent to
participate is truly informed. In particular, helping
young people to understand what the different
interventions involve and how the process of
randomisation takes place may lead to a more
fully informed consent process in clinical trials.
Considering the role of the member of the research
team taking informed consent seems relevant here.
Helping those young people who seem to be
struggling with understanding, on a case by case
basis, may be an important start. It may also be
that information sheets are not always fit for
purpose, as there can be a requirement to include
large amounts of information, even at the expense
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of making the information engaging and accessible.
Including young people in the design of information
sheets and developing innovative methods of
explaining studies, rather than relying on more
traditional patient information sheets, may be an
important element of achieving this. For example,
using interactive smart technology such as tablets
to deliver the study information and take informed
consent might help young people to engage with
the information more fully. Some concerns also
exist about the external validity of trial findings in
the light of the findings of this study. In particular,
where questionnaires are felt not to be meaningful,
young people may not be filling them in carefully
or truthfully. Likewise, the fact that the young
people reported quite positive experiences of
meeting with research assistants to review their
progress also suggests that elements of the research
protocol may have themselves been therapeutic,
potentially distorting the findings of the study
regarding clinical effectiveness. More caution may
be needed in interpreting the effects of RCTs of
psychological therapies, which are often considered
the gold standard form of assessing clinical
effectiveness, given the potential impact of the
method itself on treatment outcomes.
Strengths and limitations of the study
The study reported here is one of the first to focus on
the experience of young people taking part in a clinical
trial evaluating the effectiveness of psychological therap-
ies. The relatively large sample size, as well as findings
based on in-depth interviews in which the young people
had the opportunity to identify their own priorities and
speak about what they considered to be most significant,
add to the external validity of the study. This highlights
the strengths and benefits of using qualitative research
methods rather than pre-defined questionnaires or other
methods of quantitative data collection.
Nevertheless, this study only included those who had
already agreed to participate in the clinical trial, so some
of the barriers to participation or reasons why young
people might have chosen not to participate could not
be identified. In addition, the adolescents who took part
in the sub-study were only from one of the regions that
were involved with the IMPACT study, so their experi-
ences may not have reflected the experience of young
people based in other regions, who also took part in
this clinical trial. In addition, although the use of open-
ended interviews had a number of benefits (especially
in terms of allowing the young people to determine
which aspects of participating in the study mattered to
them), it did mean that the participants in the study
were not all systematically asked about each element of
trial participation (decision to join, understanding of
the trial procedures, experience of participating, and
impact on outcomes). For this reason, it was not always
possible to give the exact proportions of young people
who may have held various viewpoints. In particular,
when topics were not mentioned by a particular partici-
pant, it is hard to say whether this reflects the fact that
the topic was not important to them or whether they
simply did not think to speak about it. As such, the
current study is best seen as a preliminary exploratory
study that has identified a range of experiences and
views that adolescents could have when taking part in a
clinical trial of this sort. Further research (e.g. using a
standardized questionnaire) could build on this to sys-
tematically assess how common or uncommon such
views are.
Conclusions
This study highlights the importance of giving young
people who participate in clinical trials the opportunity
to report on their own experience of taking part. In
doing so, there are opportunities to better understand
what motivates young people to take part; what makes
such participation more or less acceptable; and to ex-
plore the impact of the trial participation itself on the
clinical outcomes being evaluated. This study suggests
a number of factors that need to be considered when
designing trials of psychological therapies with young
people and suggests that caution must be taken in the
interpretation of trial outcomes, given the impact of the
research framework itself.
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